IIT-Madras launches cancer genome and tissue bank; could provide breakthrough in Cancer treatment

Cancer is still one of the most fatal diseases globally, and India is no different. With increasing numbers of cancer cases every year, there is a higher demand for therapies that are specially designed according to the specific genetic profiles of Indian patients. Acting on this demand, IIT-Madras has initiated a revolutionary cancer genome and tissue bank, taking Indian personalized cancer therapy to the next level.

Revolutionizing cancer treatment

At the core of this project is the harvesting of about 7,000 tumor samples from cancer patients throughout India ( National Cancer Tissue Biobank, IIT Madras) Scientists at IIT-Madras are growing these tumor cells in the lab to experiment with different therapies. The novel strategy enables researchers to determine what works best for individual patients before giving them the actual therapies. By minimizing guesswork in cancer treatment, the process holds the potential to enhance patient outcomes and limit adverse side effects.

One of the significant findings of the IIT-Madras team is the detection of a breast cancer mutation which is more prevalent in Indian patients compared to Western populations. This discovery reflects the shortcomings of using exclusively Western genetic information for developing treatments, which might not effectively meet the needs of Indian patients. These kinds of findings reflect the need for India-centric genetic studies and treatment methods.

Apart from breast cancer, the group is also focusing on the development of genetic panels for pancreatic cancer. With the integration of global data and Indian-specific data, the scientists hope to establish markers that can diagnose pancreatic cancer at an early stage, a vital step considering how hard it is to detect and treat pancreatic cancer if it has progressed too far. The discovery of blood-based markers of early detection is also on the agenda, which could significantly enhance survival rates among pancreatic cancer patients.

Establishing a platform for medicine in India

IIT-Madras cancer genome and tissue bank is supplemented by the newly initiated Bharat Cancer Genome Atlas (BCGA), which contains genomic information of 480 breast cancer patients from all over the country (source: Official website IIT-M). The BCGA database gives an insight to researchers and clinicians about genetic mutations particular to Indian breast cancer cases. This database is open access and should expedite the progress of the development of targeted diagnostic tools and therapies specific to Indian patients.

Collectively, these efforts are transforming India's cancer research and treatment towards precision medicine, a strategy that takes into account an individual patient's specific genetic and molecular profile when making treatment decisions. Precision medicine holds out the promise of more effective therapies, earlier diagnosis, and better patient care.

With the support of government grants and collaboration with healthcare facilities like Karkinos Healthcare and Chennai Breast Clinic, IIT-Madras is leading the charge in making cancer treatment more affordable, accessible, and tailored to the Indian population.

This program is a hope for millions of cancer patients in India but it also adds humongous value to the silent war against cancer. Ongoing research and initiative, IIT-Madras plans to revolutionize how cancer is treated and understood, eventually saving lives and enhancing the quality of life of patients across the country.